25th Jan 2006 07:01
Sinclair Pharma PLC25 January 2006 SINCLAIR PHARMA STRENGTHENS BOARD PENNY FREER APPOINTED TO THE BOARD Godalming, UK; 25 January, 2006: Sinclair Pharma plc ("Sinclair" and the "Company"), the pharmaceutical company focused on the acquisition, developmentand out-licensing of niche patented products, today announces the appointment ofPenny Freer as Non-executive Director with immediate effect. Penny has been involved in small and mid-cap investment banking for almost 20years, most recently as Head of Equities in London for Robert W Baird, the USinvestment bank. Penny was previously responsible for Credit Lyonnais' smalland mid-cap equities activities. The following disclosures are being made under paragraph (g) of Schedule 2 ofthe AIM Rules. Current and Previous Directorships: CurrentCapital Markets Strategy LimitedCapital Markets Analysis LimitedThe Capital Markets Group LimitedEmpresaria Group plcPeacock Blue LimitedPilotfish Marine AB In last five yearsRobert W Baird LimitedRobert W Baird Group LimitedWilton Wright Limited Penny Freer has no interest in any ordinary shares in the Company. There are no other matters which are required to be announced with regards tothis appointment under paragraph (g) of Schedule 2 of the AIM Rules. Commenting on the appointment, Steve Harris, Chairman of Sinclair Pharma, said:"I am delighted to welcome Penny to the Board of Sinclair. In her previous roleat R.W. Baird she provided invaluable capital markets and industry advice as anadvisor to Sinclair. We now look forward to her bringing her experience andinsight to the Board as we advance the Company and product pipeline." ENDS Contact details: Sinclair Pharma plcDr Michael Flynn, CEOTel: 01483 426 6444 Financial DynamicsBen Atwell, Tel. 0207 831 3113 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Sinclair Pharma